Is BPMC a Buy, Before Earnings?
PremiumPre-EarningsIs BPMC a Buy, Before Earnings?
2M ago
Blueprint Medicines price target raised to $105 from $75 at Barclays
Premium
The Fly
Blueprint Medicines price target raised to $105 from $75 at Barclays
2M ago
Blueprint Medicines price target raised to $115 from $110 at Morgan Stanley
Premium
The Fly
Blueprint Medicines price target raised to $115 from $110 at Morgan Stanley
2M ago
Blueprint Medicines Shareholders Endorse Key Proposals
PremiumCompany AnnouncementsBlueprint Medicines Shareholders Endorse Key Proposals
3M ago
Blueprint Medicines announces avapritinib presentations at EAACI/EHA meetings
Premium
The Fly
Blueprint Medicines announces avapritinib presentations at EAACI/EHA meetings
4M ago
Blueprint Medicines initiated with an Overweight at Stephens
Premium
The Fly
Blueprint Medicines initiated with an Overweight at Stephens
4M ago
Blueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
PremiumThe FlyBlueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
5M ago
Blueprint Medicines price target raised to $75 from $70 at Barclays
Premium
The Fly
Blueprint Medicines price target raised to $75 from $70 at Barclays
5M ago
Blueprint Medicines price target raised to $114 from $99 at Oppenheimer
Premium
The Fly
Blueprint Medicines price target raised to $114 from $99 at Oppenheimer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100